XYLB — XY Labs Share Price
- $22.12m
- $20.17m
- $13.17m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.41 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -30.2% |
Financial Summary
Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | 21.62 | 11.62 | 7.61 | 13.17 | n/a | n/a | -15.23% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
XY Labs, Inc. develops, designs, and sells consumer products and applications, enterprise software and data integration solution services and blockchain and cryptographic technologies and services. The Company, through its subsidiary, XYO Foundation, provides software and technical documentation for the public good; services and support to like-minded software project communities contributing to XYO projects; and governs the use and licensing of XYO open-source assets, such as trademarks, source code, and technical papers. The XYO Network is the data aggregation and validation layer of COIN. The XYO Network provides fraud detection, data processing, and data validation for COIN. The Company is developing the second full version of the XYO Network.
Directors
- Last Annual
- December 31st, 2021
- Last Interim
- June 30th, 2022
- Incorporated
- June 22nd, 2012
- Public Since
- September 21st, 2022
- No. of Employees
- 22
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 44,249,475

- Address
- 740 13Th Street, #224, SAN DIEGO, 92101
- Web
- https://xylabs.com/
- Phone
- +1 6195076017
- Auditors
- PKF San Diego,LLP
Similar to XYLB
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advantego
Pink Sheets on Nasdaq
FAQ
As of Today at 24:11 UTC, shares in XY Labs are trading at $0.50. This share price information is delayed by 15 minutes.
Shares in XY Labs last closed at $0.50 and the price had moved by +6.38% over the past 365 days. In terms of relative price strength the XY Labs share price has underperformed the S&P500 Index by -0.61% over the past year.
There is no consensus recommendation for this security.
Find out moreXY Labs does not currently pay a dividend.
XY Labs does not currently pay a dividend.
XY Labs does not currently pay a dividend.
To buy shares in XY Labs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.50, shares in XY Labs had a market capitalisation of $22.12m.
Here are the trading details for XY Labs:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: XYLB
Based on an overall assessment of its quality, value and momentum XY Labs is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like XY Labs. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $0.50, shares in XY Labs were trading +33.46% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The XY Labs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on XY Labs' directors